Cognitive Impairment Due to Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Cognitive Impairment Due to Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Study to Assess Safety and Efficacy of PRI-002 in Patients With MCI to Mild Dementia Due to Alzheimer's Disease (AD) [Phase 2]
This Phase 2 trial is evaluating the safety and efficacy of PRI-002 in patients with mild cognitive impairment due to Alzheimer's disease an…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Efficacy of Lecanemab at Different Therapeutic Doses for Alzheimer's Disease (AD) in Real-World Practice
A clinical trial registry entry outlines evaluating lecanemab at various doses for Alzheimer's disease in real-world practice; the study sta…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Assessment of Foralumab Safety and Modulation of Microglial Activation in Alzheimer's Disease [Phase 2]
A Phase 2 clinical trial evaluating the safety and potential modulation of microglial activation by foralumab in Alzheimer's disease-related…
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: Autophagy-Enhancers to Reduce Sleep Disturbances [NA]
A clinical trial update from University Medicine Greifswald evaluating autophagy-enhancers to reduce sleep disturbances in people with mild …
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: Infrared Light for Memory Loss in Mild Cognitive Impairment (MCI) [NA]
This clinical trial in Toronto is recruiting to evaluate infrared light therapy for memory loss in individuals with mild cognitive impairmen…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-09-08Clinical Trial Update: [18F]APN-1607 PET in Subjects With AD Compared to HC [Phase 3]
A Phase 3 study evaluating the PET radiotracer [18F]APN-1607 in Alzheimer's disease and mild cognitive impairment due to Alzheimer's disease…
-
CLINICAL_TRIALS research · 2025-08-14Clinical Trial Update: Alzheimer's Disease Multinuclear Imaging Neuro-Enhanced Resolution (AD-MINER)
A clinical trial named AD-MINER is currently recruiting to evaluate multinuclear imaging for Alzheimer's disease and mild cognitive impairme…
-
CLINICAL_TRIALS trial_result · 2025-07-04Clinical Trial Update: Biomarkers of Cognitive Impairment in Blood Cells
A completed clinical trial from the University of the Balearic Islands studied blood-cell biomarkers of cognitive impairment linked to Alzhe…
-
CLINICAL_TRIALS research · 2025-05-18Clinical Trial Update: A Study to Learn About the Safety of BIIB080 Injections and Whether They Can Improve Symptoms of Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD Dementia Between 50 to 80 Years of Age [Phase 2]
A Phase 2 clinical trial evaluating the safety of BIIB080 injections and whether they can improve cognitive symptoms in adults aged 50-80 wi…
-
CLINICAL_TRIALS research · 2025-03-10Clinical Trial Update: Efficacy and Safety of Conventional Symptomatic Drugs Combined with Lencanizumab in the Treatment of Early Alzheimer's Disease: a Multicenter, Prospective, Observational Study
A multicenter, prospective observational study evaluating the safety and efficacy of combining conventional symptomatic Alzheimer's therapie…
-
CLINICAL_TRIALS research · 2025-01-27Clinical Trial Update: Mindfulness for Cognition in Early-stage Alzheimer's Disease [NA]
The VA Boston Healthcare System is recruiting for a study to assess mindfulness-based approaches to support cognition in individuals with mi…
-
CLINICAL_TRIALS research · 2025-01-15Clinical Trial Update: A Diagnostic Test for Dementia With Lewy Bodies
Clinical trial update describing a diagnostic test for Dementia with Lewy Bodies that is currently active but not recruiting, applicable to …
-
CLINICAL_TRIALS research · 2024-07-18Clinical Trial Update: Language, Speech and Motor Function in MCI Due to AD and Alzheimer's Disease
Ongoing clinical trial evaluating language, speech, and motor function in individuals with Alzheimer's disease and mild cognitive impairment…
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: Evaluation of [18F]APN-1607 PET Uptake in Alzheimer's Disease Patients Compared With Healthy Subjects [Phase 2]
Phase 2 clinical trial evaluating [18F]APN-1607 PET uptake in Alzheimer's disease patients versus healthy subjects; status currently unknown…
-
CLINICAL_TRIALS trial_result · 2019-08-14Clinical Trial Update: Biomarker Qualification for Risk of Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease (AD) and Safety and Efficacy Evaluation of Pioglitazone in Delaying Its Onset [Phase 3]
Phase 3 trial evaluating pioglitazone for delaying onset of mild cognitive impairment due to Alzheimer's disease; trial terminated with resu…
-
CLINICAL_TRIALS trial_result · 2019-07-02Clinical Trial Update: AD-4833/TOMM40_303 Extension Study of the Safety and Efficacy of Pioglitazone to Slow Cognitive Decline in Participants With Mild Cognitive Impairment Due to Alzheimer Disease [Phase 3]
Phase 3 extension study evaluating pioglitazone for slowing cognitive decline in mild cognitive impairment due to Alzheimer's disease; study…
-
CLINICAL_TRIALS trial_result · 2018-01-31Clinical Trial Update: Dosage and Efficacy of Probucol-induced apoE to Negate Cognitive Deterioration [Phase 1, Phase 2]
A clinical trial investigating probucol-induced apoE to mitigate cognitive deterioration has completed Phase 1 and Phase 2 studies focused o…